Biotech stocks are experiencing significant moves in pre-market activity on Wednesday, indicating potential trading opportunities.
By evaluating sentiment and momentum before the bell, pre-market analysis becomes a foundational step in any trader's pre-market routine.
In the Green - Pre-market Gainers
On Wednesday, the following stocks are trading significantly higher in the pre-market session.
1. Capricor Therapeutics Inc. (CAPR) - up 18% at $7.512. Anixa Biosciences Inc. (ANIX) - up 12% at $4.723. Inflarx NV. (IFRX) - up 4% at $1.034. Protara Therapeutics Inc. (TARA) - up 3% at $6.385. Lexeo Therapeutics Inc. (LXEO) - up 2% at $8.486. Rani Therapeutics Holdings Inc. (RANI) - up 2% at $0.567. Cosmos Health Inc. (COSM) - up 2% at $0.568. Dyne Therapeutics Inc. (DYN) - up 1% at $20.169. Zevra Therapeutics Inc. (ZVRA) - up 1% at $8.2610. Coherus Oncology Inc. (CHRS) - up 1% at $1.15
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.